Calcium channel blockers and clinical outcomes in patients with continuous ‐flow left ventricular assist devices

ConclusionsIn patients with LVAD, CCB therapy fails to show benefits in long-term survival and is associated with increased incidences of neurological dysfunction, bleeding, renal dysfunction, and rehospitalization.

Source: ESC Heart Failure - November 16, 2023 Category: Cardiology Authors: Hongtao Tie, Zhenhan Li, Henryk Welp, Avirup Guha, C ésar Caraballo, Heinz Deschka, Rui Shi, Xiaoqing Zheng, Sven Martens, Jürgen Sindermann, Dan Chen, Qingchen Wu, Sabrina Martens Tags: Original Article Source Type: research